InspireMD (NSPR) Cash & Current Investments (2010 - 2025)

InspireMD's Cash & Current Investments history runs 16 years deep, the most recent figure standing at $54.2 million for Q4 2025.

• On a quarterly basis, Cash & Current Investments rose 56.51% year-over-year to $54.2 million in Q4 2025; TTM through Dec 2025 was $54.2 million, a 56.51% increase from a year earlier, with the FY2025 full-year figure at $54.2 million, up 56.51% from the prior year.
• Cash & Current Investments retreated to $54.2 million in Q4 2025 per NSPR's latest filing, from $63.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $63.4 million in Q3 2025 and bottomed at $12.9 million in Q1 2023.
• The 5-year median for Cash & Current Investments is $35.9 million (2021), against an average of $35.3 million.
• Across the five-year window, Cash & Current Investments soared 1301.91% in 2021 and tumbled 58.92% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $34.0 million in 2021, then plunged by 47.7% to $17.8 million in 2022, then soared by 119.19% to $39.0 million in 2023, then slipped by 11.24% to $34.6 million in 2024, then soared by 56.51% to $54.2 million in 2025.
• Per Business Quant, the three latest NSPR Cash & Current Investments figures stand at $54.2 million (Q4 2025), $63.4 million (Q3 2025), and $19.4 million (Q2 2025).